Page results
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
UCLH is the first NHS trust to pilot a personalised educational package for patients living with stroke.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
This information will give you an overview of BCG immunotherapy, how it is given and side effects it may cause.
-
UCLH will play a vital role in a new respiratory virus study.
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease.
-
King Charles III and Queen Camilla met patients and families living with cancer to hear their hopes and fears as they received care at UCLH in London today.
-
RNOH are pleased to launch a series of regular Health and Wellbeing Information and Support Sessions to support patients following a cancer diagnosis and also during/after treatment. These…
File results
-
FOI/2023/0914 - Agency use of physiotherapy and occupational therapists
-
FOI/2023/0916 - Gender options on patient forms
-
FOI/2023/0917 - Patient Initiated Digital Mutual Aid System (PIDMAS)
-
FOI/2023/0921 - Trust provider for sexual health platform
-
FOI/2023/0923 - Proton Beam Therapy treatments
-
FOI/2023/0925 - Stereotactic radiosurgery treatment/ gamma knife treatment
-
FOI/2023/0926 - Electronic Patient Record Supplier (EPR) contract
-
FOI/2023/0930 - Patient deaths while on waiting list 2018-2023
-
FOI/2023/0931 - Trust surgical and equipment drape usage in theatre departments
-
FOI/2023/0934 - Treatment for Haemophilia B and Von Willebrand disease